Roberto Cerrato

Director Launch Excellence (CEMEA Region) at Alnylam Pharmaceuticals at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Roberto Cerrato's Colleagues at Alnylam Pharmaceuticals
Sarah Newell

Packaging and Labelling Coordinator

Contact Sarah Newell

Thomas Kruijver

Director - Controller EU & Canada

Contact Thomas Kruijver

Gertruud Haitsma

Sr Manager Market Access, Pricing & Policy CEMEA

Contact Gertruud Haitsma

Marielle Bouma

Associate Director Manufacturing

Contact Marielle Bouma

Kathy Mathijssen

International Payroll lead

Contact Kathy Mathijssen

Martin Durec

Accounting Manager Canada & EMEA

Contact Martin Durec

View All Roberto Cerrato's Colleagues
Roberto Cerrato's Contact Details
HQ
(617) 551-8200
Location
Amsterdam, North Holland, Netherlands
Company
Alnylam Pharmaceuticals
Roberto Cerrato's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Roberto Cerrato
Roberto Cerrato currently works for Alnylam Pharmaceuticals.
Roberto Cerrato's role at Alnylam Pharmaceuticals is Director Launch Excellence (CEMEA Region) at Alnylam Pharmaceuticals.
Roberto Cerrato's email address is ***@alnylam.com. To view Roberto Cerrato's full email address, please signup to ConnectPlex.
Roberto Cerrato works in the SaaS industry.
Roberto Cerrato's colleagues at Alnylam Pharmaceuticals are Sarah Newell, Simon Jensen, Thomas Kruijver, Gertruud Haitsma, Marielle Bouma, Kathy Mathijssen, Martin Durec and others.
Roberto Cerrato's phone number is (617) 551-8200
See more information about Roberto Cerrato